Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar
UW 22-704
Unknown small_molecule active
Quick answer
Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar for Recurrent Ovarian Carcinoma is a Unknown program (small_molecule) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The University of Hong Kong
- Indication
- Recurrent Ovarian Carcinoma
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active